• Home
  • Events
  • Real World Evidence in the COVID Era: A New Treatment Option

Real World Evidence in the COVID Era: A New Treatment Option

Month Flat Week Day
  • Categories
  • Print
Date: Wednesday, October 27, 2021 2:00 pm - 3:00 pm
Categories: TraCS-sponsored

Real World Evidence in the COVID Era: A New Treatment Option

Join the NC TraCS Comparative Effectiveness Research team and guest expert Timothy Sheahan, PhD, to discuss the phase 2 trial results of molnupiravir, the new potential treatment for COVID-19.

Journal article for this discussion: Molnupiravir, an Oral Antiviral Treatment for COVID-19 - https://www.medrxiv.org/content/10.1101/2021.06.17.21258639v1

Discussion Leaders

Michele Jonsson-Funk, PhD, Associate Professor
Epidemiology, Gillings School of Global Public Health

Timothy Sheahan, PhD Assistant Professor
Epidemiology, Gillings School of Public Health

Sara Dejene, PhD Candidate
Epidemiology, Gillings School of Global Public Health


Register

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

Need help advertising your event? Contact Michelle Maclay at michelle_maclay@med.unc.edu

NC TraCS Institute logo vertical

In partnership with:

Contact Us

Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social

Cite Us

CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact